Renal Cancer

June 1, 2018

Targeted Therapy and Renal Cell Carcinoma: Are We Making Progress?

Charles H. Weaver, MD
June 1, 2018

Everolimus Improves Progression-Free Survival in Kidney Cancer

Charles H. Weaver, MD
June 1, 2018

Cardiac Toxicity in Patients with MRCC Receiving Tyrosine Kinase Inhibitors

Charles H. Weaver, MD
June 1, 2018

Neovastat Doubles Survival Time for Patients with Advanced Renal Cancer

Charles H. Weaver, MD
June 1, 2018

Nexavar® Improves Progression-free Survival in Advanced Kidney Cancer

Charles H. Weaver, MD
June 1, 2018

Addition of Erbitux® to XELOX Reduces Cancer Progression as First-line Therapy

Charles H. Weaver, MD
June 1, 2018

Drinking More Fluids May Reduce the Risk for Bladder Cancer in Men

Charles H. Weaver, MD
June 1, 2018

Surgery Prior to Interferon Improves Survival in Advanced Renal Cell Carcinoma

Charles H. Weaver, MD
June 1, 2018

New Treatments Improve Outcomes for Metastatic Kidney Cancer

Charles H. Weaver, MD
June 1, 2018

FDA Approves Torisel™ For Kidney Cancer

Charles H. Weaver, MD
June 1, 2018

High Levels of Survivin Associated with Poorer Survival in Renal Cell Carcinoma

Charles H. Weaver, MD
June 1, 2018

Adhesive Instead of Stitches May Reduce Surgery Complications in Kidney Cancer

Charles H. Weaver, MD